CLRB - Company ID 0001279704
Cellectar Biosciences, Inc. trades as CLRB. This page tracks Cellectar Biosciences, Inc. through 1,001 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| S-1/A | - | 2026-05-29 |
| IPO registration | S-1 | 2026-05-19 |
| PRE 14A | - | 2026-05-18 |
| Major company event | 8-K | 2026-05-18 |
| Major company event | 8-K | 2026-05-14 |
| Quarterly report | 10-Q | 2026-05-14 |
| Insider trade | 4 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
The largest companies sharing Cellectar Biosciences, Inc.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year Cellectar Biosciences, Inc. reported a net loss of $21.79M.